Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Association for the Cannabinoid Industry (ACI) is a UK-based trade association and regulatory consultancy dedicated to the development of a safe, legal, and well-regulated cannabinoid market. Founded in 2019, the organization provides its members with essential guidance on navigating complex regulatory frameworks, specifically the UK Food Standards Agency's (FSA) Novel Foods authorization process. ACI offers services including quality auditing, laboratory testing standards, and advocacy to ensure consumer safety and industry compliance. By fostering collaboration between businesses, scientists, and policymakers, ACI aims to establish the UK as a global leader in cannabinoid innovation and quality assurance. The organization also focuses on clinical research and data collection to validate the safety profiles of CBD-based products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Association for the Cannabinoid Industry.